Structure

Physi-Chem Properties

Molecular Weight:  402.1
Volume:  378.271
LogP:  1.426
LogD:  0.839
LogS:  -4.115
# Rotatable Bonds:  2
TPSA:  160.82
# H-Bond Aceptor:  9
# H-Bond Donor:  6
# Rings:  4
# Heavy Atoms:  9

MedChem Properties

QED Drug-Likeness Score:  0.363
Synthetic Accessibility Score:  3.872
Fsp3:  0.25
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Accepted
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -5.828
MDCK Permeability:  4.583911959343823e-06
Pgp-inhibitor:  0.003
Pgp-substrate:  0.977
Human Intestinal Absorption (HIA):  0.634
20% Bioavailability (F20%):  0.568
30% Bioavailability (F30%):  1.0

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.022
Plasma Protein Binding (PPB):  91.85668182373047%
Volume Distribution (VD):  0.878
Pgp-substrate:  10.136412620544434%

ADMET: Metabolism

CYP1A2-inhibitor:  0.255
CYP1A2-substrate:  0.078
CYP2C19-inhibitor:  0.03
CYP2C19-substrate:  0.052
CYP2C9-inhibitor:  0.132
CYP2C9-substrate:  0.653
CYP2D6-inhibitor:  0.176
CYP2D6-substrate:  0.166
CYP3A4-inhibitor:  0.083
CYP3A4-substrate:  0.027

ADMET: Excretion

Clearance (CL):  4.837
Half-life (T1/2):  0.694

ADMET: Toxicity

hERG Blockers:  0.077
Human Hepatotoxicity (H-HT):  0.161
Drug-inuced Liver Injury (DILI):  0.972
AMES Toxicity:  0.824
Rat Oral Acute Toxicity:  0.065
Maximum Recommended Daily Dose:  0.021
Skin Sensitization:  0.798
Carcinogencity:  0.248
Eye Corrosion:  0.003
Eye Irritation:  0.188
Respiratory Toxicity:  0.148

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC477897

Natural Product ID:  NPC477897
Common Name*:   5,7-dihydroxy-2-(4-hydroxyphenyl)-8-[(2S,3R,4S,5S)-3,4,5-trihydroxyoxan-2-yl]chromen-4-one
IUPAC Name:   5,7-dihydroxy-2-(4-hydroxyphenyl)-8-[(2S,3R,4S,5S)-3,4,5-trihydroxyoxan-2-yl]chromen-4-one
Synonyms:  
Standard InCHIKey:  YCCJEBDPVUMZGE-NTCOEUGSSA-N
Standard InCHI:  InChI=1S/C20H18O9/c21-9-3-1-8(2-4-9)14-6-12(24)15-10(22)5-11(23)16(19(15)29-14)20-18(27)17(26)13(25)7-28-20/h1-6,13,17-18,20-23,25-27H,7H2/t13-,17-,18+,20-/m0/s1
SMILES:  C1[C@@H]([C@@H]([C@H]([C@@H](O1)C2=C(C=C(C3=C2OC(=CC3=O)C4=CC=C(C=C4)O)O)O)O)O)O
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   n.a.
PubChem CID:   118707634
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000261] Phenylpropanoids and polyketides
      • [CHEMONTID:0000334] Flavonoids
        • [CHEMONTID:0001111] Flavonoid glycosides
          • [CHEMONTID:0001737] Flavonoid C-glycosides
            • [CHEMONTID:0003535] Flavonoid 8-C-glycosides

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO15289 Scoparia dulcis Species Plantaginaceae Eukaryota n.a. n.a. n.a. PMID[12880314]
NPO15289 Scoparia dulcis Species Plantaginaceae Eukaryota n.a. whole plant n.a. PMID[1294695]
NPO15289 Scoparia dulcis Species Plantaginaceae Eukaryota n.a. n.a. n.a. PMID[15104516]
NPO15289 Scoparia dulcis Species Plantaginaceae Eukaryota leaves and twigs Taiwan n.a. PMID[1659612]
NPO15289 Scoparia dulcis Species Plantaginaceae Eukaryota aerial parts Nanning, Guangxi Zhuang Autonomous Region, Peoples Republic of China 2012-OCT PMID[24955889]
NPO15289 Scoparia dulcis Species Plantaginaceae Eukaryota n.a. n.a. n.a. Database[HerDing]
NPO15289 Scoparia dulcis Species Plantaginaceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO15289 Scoparia dulcis Species Plantaginaceae Eukaryota n.a. n.a. n.a. Database[TCM_Taiwan]
NPO15289 Scoparia dulcis Species Plantaginaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT1618 Individual Protein Peroxisome proliferator-activated receptor gamma Mus musculus EC50 > 100000 nM PMID[24955889]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC477897 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
1.0 High Similarity NPC289774
1.0 High Similarity NPC328740
1.0 High Similarity NPC209846
0.9931 High Similarity NPC56232
0.9931 High Similarity NPC244583
0.9931 High Similarity NPC10807
0.9931 High Similarity NPC161881
0.9931 High Similarity NPC150123
0.9863 High Similarity NPC109594
0.9863 High Similarity NPC268193
0.9863 High Similarity NPC326592
0.9863 High Similarity NPC112701
0.9796 High Similarity NPC111341
0.9796 High Similarity NPC304745
0.9793 High Similarity NPC177308
0.9793 High Similarity NPC124478
0.9728 High Similarity NPC472583
0.9728 High Similarity NPC223701
0.9728 High Similarity NPC7989
0.9662 High Similarity NPC470681
0.9662 High Similarity NPC259710
0.9662 High Similarity NPC304207
0.9662 High Similarity NPC217706
0.9662 High Similarity NPC207809
0.9662 High Similarity NPC48579
0.966 High Similarity NPC475790
0.9655 High Similarity NPC10097
0.96 High Similarity NPC117418
0.96 High Similarity NPC53545
0.9595 High Similarity NPC469405
0.9595 High Similarity NPC248793
0.9595 High Similarity NPC20907
0.9595 High Similarity NPC180301
0.9595 High Similarity NPC244250
0.9592 High Similarity NPC262038
0.9592 High Similarity NPC254412
0.9592 High Similarity NPC244577
0.9592 High Similarity NPC472420
0.9592 High Similarity NPC263384
0.9592 High Similarity NPC319910
0.9592 High Similarity NPC278476
0.9592 High Similarity NPC474021
0.9592 High Similarity NPC262039
0.9592 High Similarity NPC471677
0.9592 High Similarity NPC472422
0.9592 High Similarity NPC474023
0.9592 High Similarity NPC471676
0.9589 High Similarity NPC89442
0.9589 High Similarity NPC307052
0.9589 High Similarity NPC139966
0.953 High Similarity NPC477958
0.9527 High Similarity NPC35567
0.9527 High Similarity NPC243171
0.9527 High Similarity NPC217149
0.9527 High Similarity NPC216035
0.9527 High Similarity NPC138288
0.9527 High Similarity NPC171651
0.9524 High Similarity NPC105136
0.9517 High Similarity NPC472629
0.9474 High Similarity NPC26326
0.9474 High Similarity NPC47923
0.9474 High Similarity NPC289771
0.947 High Similarity NPC123544
0.9467 High Similarity NPC78492
0.9467 High Similarity NPC20530
0.9467 High Similarity NPC208152
0.9467 High Similarity NPC215917
0.9467 High Similarity NPC10754
0.9463 High Similarity NPC311579
0.9463 High Similarity NPC293286
0.9463 High Similarity NPC236756
0.9459 High Similarity NPC472636
0.9459 High Similarity NPC471675
0.9456 High Similarity NPC5173
0.9456 High Similarity NPC472628
0.9452 High Similarity NPC473077
0.9452 High Similarity NPC296998
0.9452 High Similarity NPC85773
0.9452 High Similarity NPC472627
0.9448 High Similarity NPC470890
0.9448 High Similarity NPC87486
0.9448 High Similarity NPC224714
0.9448 High Similarity NPC124780
0.9412 High Similarity NPC131745
0.9412 High Similarity NPC44947
0.9408 High Similarity NPC472320
0.9408 High Similarity NPC475784
0.9404 High Similarity NPC161749
0.9404 High Similarity NPC197896
0.9404 High Similarity NPC313163
0.9404 High Similarity NPC258035
0.9404 High Similarity NPC156457
0.94 High Similarity NPC476169
0.94 High Similarity NPC477530
0.9396 High Similarity NPC285623
0.9396 High Similarity NPC327269
0.9396 High Similarity NPC473996
0.9396 High Similarity NPC476238
0.9396 High Similarity NPC31627
0.9392 High Similarity NPC472633
0.9384 High Similarity NPC67805
0.9384 High Similarity NPC312973
0.9384 High Similarity NPC176229
0.9384 High Similarity NPC20488
0.9384 High Similarity NPC195621
0.9384 High Similarity NPC214774
0.9384 High Similarity NPC474302
0.9384 High Similarity NPC142405
0.9384 High Similarity NPC267375
0.9384 High Similarity NPC475052
0.9384 High Similarity NPC88964
0.9384 High Similarity NPC301276
0.9384 High Similarity NPC83357
0.9384 High Similarity NPC470647
0.9384 High Similarity NPC246948
0.9384 High Similarity NPC54577
0.9384 High Similarity NPC111786
0.9351 High Similarity NPC66087
0.9351 High Similarity NPC124155
0.9351 High Similarity NPC183672
0.9351 High Similarity NPC278419
0.9351 High Similarity NPC257566
0.9351 High Similarity NPC179198
0.9346 High Similarity NPC97812
0.9346 High Similarity NPC142252
0.9346 High Similarity NPC474038
0.9342 High Similarity NPC73511
0.9338 High Similarity NPC471787
0.9333 High Similarity NPC88983
0.9333 High Similarity NPC83283
0.9333 High Similarity NPC210003
0.9333 High Similarity NPC143851
0.9333 High Similarity NPC39360
0.9333 High Similarity NPC29763
0.9329 High Similarity NPC472580
0.9329 High Similarity NPC474744
0.9329 High Similarity NPC472423
0.9329 High Similarity NPC474772
0.932 High Similarity NPC3779
0.932 High Similarity NPC47388
0.932 High Similarity NPC91902
0.932 High Similarity NPC44721
0.932 High Similarity NPC470670
0.932 High Similarity NPC23728
0.932 High Similarity NPC211466
0.932 High Similarity NPC110303
0.932 High Similarity NPC476182
0.932 High Similarity NPC473133
0.932 High Similarity NPC40086
0.932 High Similarity NPC283234
0.932 High Similarity NPC122828
0.932 High Similarity NPC176869
0.932 High Similarity NPC51070
0.932 High Similarity NPC222298
0.9315 High Similarity NPC49130
0.9315 High Similarity NPC4152
0.9315 High Similarity NPC326506
0.9315 High Similarity NPC470136
0.9315 High Similarity NPC279417
0.9315 High Similarity NPC470135
0.9315 High Similarity NPC39045
0.9315 High Similarity NPC142731
0.9315 High Similarity NPC62290
0.9315 High Similarity NPC319752
0.9315 High Similarity NPC208176
0.9315 High Similarity NPC306607
0.931 High Similarity NPC194432
0.931 High Similarity NPC227579
0.931 High Similarity NPC64915
0.931 High Similarity NPC166482
0.931 High Similarity NPC107572
0.931 High Similarity NPC10937
0.931 High Similarity NPC76372
0.931 High Similarity NPC223500
0.931 High Similarity NPC78
0.931 High Similarity NPC125855
0.931 High Similarity NPC228504
0.931 High Similarity NPC32739
0.931 High Similarity NPC37496
0.931 High Similarity NPC182852
0.931 High Similarity NPC76338
0.931 High Similarity NPC324134
0.931 High Similarity NPC167624
0.931 High Similarity NPC161506
0.931 High Similarity NPC328164
0.931 High Similarity NPC148757
0.931 High Similarity NPC324436
0.931 High Similarity NPC66515
0.931 High Similarity NPC177354
0.931 High Similarity NPC40833
0.931 High Similarity NPC166934
0.931 High Similarity NPC306829
0.931 High Similarity NPC296917
0.931 High Similarity NPC220998
0.931 High Similarity NPC265040
0.931 High Similarity NPC1089
0.9286 High Similarity NPC259834
0.9281 High Similarity NPC118256
0.9281 High Similarity NPC119209
0.9281 High Similarity NPC192686

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC477897 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.9793 High Similarity NPD4380 Phase 2
0.9404 High Similarity NPD4381 Clinical (unspecified phase)
0.9205 High Similarity NPD2393 Clinical (unspecified phase)
0.9184 High Similarity NPD4378 Clinical (unspecified phase)
0.915 High Similarity NPD7075 Discontinued
0.9114 High Similarity NPD7804 Clinical (unspecified phase)
0.9097 High Similarity NPD1552 Clinical (unspecified phase)
0.9097 High Similarity NPD1550 Clinical (unspecified phase)
0.9034 High Similarity NPD1549 Phase 2
0.902 High Similarity NPD8443 Clinical (unspecified phase)
0.9013 High Similarity NPD6801 Discontinued
0.9013 High Similarity NPD1934 Approved
0.8954 High Similarity NPD7096 Clinical (unspecified phase)
0.8926 High Similarity NPD7410 Clinical (unspecified phase)
0.8924 High Similarity NPD6168 Clinical (unspecified phase)
0.8924 High Similarity NPD6167 Clinical (unspecified phase)
0.8924 High Similarity NPD6166 Phase 2
0.8828 High Similarity NPD1510 Phase 2
0.8824 High Similarity NPD7411 Suspended
0.8767 High Similarity NPD2796 Approved
0.8758 High Similarity NPD7054 Approved
0.8733 High Similarity NPD1511 Approved
0.871 High Similarity NPD2801 Approved
0.8704 High Similarity NPD7074 Phase 3
0.8704 High Similarity NPD7472 Approved
0.8696 High Similarity NPD3818 Discontinued
0.8684 High Similarity NPD5403 Approved
0.865 High Similarity NPD6797 Phase 2
0.8618 High Similarity NPD1512 Approved
0.8616 High Similarity NPD6959 Discontinued
0.8599 High Similarity NPD4868 Clinical (unspecified phase)
0.8598 High Similarity NPD7251 Discontinued
0.859 High Similarity NPD7819 Suspended
0.8553 High Similarity NPD5401 Approved
0.8545 High Similarity NPD7808 Phase 3
0.8545 High Similarity NPD4338 Clinical (unspecified phase)
0.8535 High Similarity NPD5402 Approved
0.8535 High Similarity NPD3817 Phase 2
0.8487 Intermediate Similarity NPD6799 Approved
0.8485 Intermediate Similarity NPD6559 Discontinued
0.8457 Intermediate Similarity NPD7852 Clinical (unspecified phase)
0.8438 Intermediate Similarity NPD5494 Approved
0.8425 Intermediate Similarity NPD1240 Approved
0.8365 Intermediate Similarity NPD3882 Suspended
0.8311 Intermediate Similarity NPD1607 Approved
0.8289 Intermediate Similarity NPD3750 Approved
0.828 Intermediate Similarity NPD6599 Discontinued
0.825 Intermediate Similarity NPD7768 Phase 2
0.8204 Intermediate Similarity NPD7993 Clinical (unspecified phase)
0.8193 Intermediate Similarity NPD5844 Phase 1
0.811 Intermediate Similarity NPD6232 Discontinued
0.8105 Intermediate Similarity NPD7421 Clinical (unspecified phase)
0.8105 Intermediate Similarity NPD2800 Approved
0.8086 Intermediate Similarity NPD3749 Approved
0.8072 Intermediate Similarity NPD7473 Discontinued
0.8052 Intermediate Similarity NPD4628 Phase 3
0.8026 Intermediate Similarity NPD1551 Phase 2
0.8 Intermediate Similarity NPD4419 Clinical (unspecified phase)
0.7975 Intermediate Similarity NPD920 Approved
0.7966 Intermediate Similarity NPD8090 Clinical (unspecified phase)
0.7962 Intermediate Similarity NPD642 Clinical (unspecified phase)
0.7961 Intermediate Similarity NPD3748 Approved
0.7955 Intermediate Similarity NPD4363 Phase 3
0.7955 Intermediate Similarity NPD4360 Phase 2
0.7949 Intermediate Similarity NPD643 Clinical (unspecified phase)
0.7947 Intermediate Similarity NPD6651 Approved
0.7933 Intermediate Similarity NPD1612 Clinical (unspecified phase)
0.7933 Intermediate Similarity NPD1613 Approved
0.7922 Intermediate Similarity NPD970 Clinical (unspecified phase)
0.7919 Intermediate Similarity NPD4907 Clinical (unspecified phase)
0.7919 Intermediate Similarity NPD2313 Discontinued
0.7919 Intermediate Similarity NPD6859 Clinical (unspecified phase)
0.7908 Intermediate Similarity NPD2935 Discontinued
0.7901 Intermediate Similarity NPD1465 Phase 2
0.7882 Intermediate Similarity NPD5953 Discontinued
0.7871 Intermediate Similarity NPD1243 Approved
0.7869 Intermediate Similarity NPD7584 Approved
0.7849 Intermediate Similarity NPD8313 Approved
0.7849 Intermediate Similarity NPD8312 Approved
0.7848 Intermediate Similarity NPD2533 Approved
0.7848 Intermediate Similarity NPD2534 Approved
0.7848 Intermediate Similarity NPD2532 Approved
0.7841 Intermediate Similarity NPD7879 Clinical (unspecified phase)
0.7821 Intermediate Similarity NPD1878 Clinical (unspecified phase)
0.7793 Intermediate Similarity NPD1547 Clinical (unspecified phase)
0.7791 Intermediate Similarity NPD8455 Phase 2
0.7785 Intermediate Similarity NPD4908 Phase 1
0.7765 Intermediate Similarity NPD7286 Phase 2
0.7763 Intermediate Similarity NPD5124 Phase 1
0.7763 Intermediate Similarity NPD5123 Clinical (unspecified phase)
0.7727 Intermediate Similarity NPD2799 Discontinued
0.7727 Intermediate Similarity NPD7033 Discontinued
0.7725 Intermediate Similarity NPD1247 Approved
0.7711 Intermediate Similarity NPD919 Approved
0.7706 Intermediate Similarity NPD3751 Discontinued
0.7697 Intermediate Similarity NPD943 Approved
0.7679 Intermediate Similarity NPD3787 Discontinued
0.7673 Intermediate Similarity NPD7390 Discontinued
0.7671 Intermediate Similarity NPD1610 Phase 2
0.7667 Intermediate Similarity NPD1529 Clinical (unspecified phase)
0.7654 Intermediate Similarity NPD3226 Approved
0.7639 Intermediate Similarity NPD1548 Phase 1
0.7628 Intermediate Similarity NPD2344 Approved
0.7625 Intermediate Similarity NPD7004 Clinical (unspecified phase)
0.76 Intermediate Similarity NPD1530 Clinical (unspecified phase)
0.7584 Intermediate Similarity NPD1203 Approved
0.758 Intermediate Similarity NPD2424 Discontinued
0.7564 Intermediate Similarity NPD6099 Approved
0.7564 Intermediate Similarity NPD6100 Approved
0.7561 Intermediate Similarity NPD7615 Clinical (unspecified phase)
0.755 Intermediate Similarity NPD6832 Phase 2
0.7546 Intermediate Similarity NPD5808 Clinical (unspecified phase)
0.7541 Intermediate Similarity NPD6781 Approved
0.7541 Intermediate Similarity NPD6780 Approved
0.7541 Intermediate Similarity NPD6782 Approved
0.7541 Intermediate Similarity NPD6776 Approved
0.7541 Intermediate Similarity NPD6778 Approved
0.7541 Intermediate Similarity NPD6777 Approved
0.7541 Intermediate Similarity NPD6779 Approved
0.7532 Intermediate Similarity NPD1652 Phase 2
0.7529 Intermediate Similarity NPD3926 Phase 2
0.7516 Intermediate Similarity NPD2346 Discontinued
0.7514 Intermediate Similarity NPD4361 Phase 2
0.7514 Intermediate Similarity NPD4362 Clinical (unspecified phase)
0.75 Intermediate Similarity NPD3027 Phase 3
0.75 Intermediate Similarity NPD1509 Clinical (unspecified phase)
0.7485 Intermediate Similarity NPD1653 Approved
0.7451 Intermediate Similarity NPD3268 Approved
0.7451 Intermediate Similarity NPD6798 Discontinued
0.7447 Intermediate Similarity NPD7585 Approved
0.7446 Intermediate Similarity NPD7501 Clinical (unspecified phase)
0.7439 Intermediate Similarity NPD7458 Discontinued
0.7438 Intermediate Similarity NPD2309 Approved
0.743 Intermediate Similarity NPD8397 Clinical (unspecified phase)
0.7423 Intermediate Similarity NPD6980 Clinical (unspecified phase)
0.7419 Intermediate Similarity NPD7435 Discontinued
0.7417 Intermediate Similarity NPD2798 Approved
0.7416 Intermediate Similarity NPD8150 Discontinued
0.7416 Intermediate Similarity NPD8434 Phase 2
0.7412 Intermediate Similarity NPD7199 Phase 2
0.741 Intermediate Similarity NPD6844 Discontinued
0.7407 Intermediate Similarity NPD8151 Discontinued
0.74 Intermediate Similarity NPD3225 Approved
0.7394 Intermediate Similarity NPD7583 Approved
0.7384 Intermediate Similarity NPD7784 Clinical (unspecified phase)
0.7375 Intermediate Similarity NPD6398 Clinical (unspecified phase)
0.7371 Intermediate Similarity NPD3823 Discontinued
0.7368 Intermediate Similarity NPD5711 Approved
0.7368 Intermediate Similarity NPD5710 Approved
0.7351 Intermediate Similarity NPD2797 Approved
0.733 Intermediate Similarity NPD7783 Phase 2
0.733 Intermediate Similarity NPD7782 Clinical (unspecified phase)
0.7329 Intermediate Similarity NPD6190 Approved
0.7326 Intermediate Similarity NPD7696 Phase 3
0.7326 Intermediate Similarity NPD7698 Approved
0.7326 Intermediate Similarity NPD7697 Approved
0.7321 Intermediate Similarity NPD4288 Approved
0.7315 Intermediate Similarity NPD422 Phase 1
0.7308 Intermediate Similarity NPD230 Phase 1
0.7308 Intermediate Similarity NPD6355 Discontinued
0.7308 Intermediate Similarity NPD1933 Approved
0.7305 Intermediate Similarity NPD37 Approved
0.7301 Intermediate Similarity NPD4662 Approved
0.7301 Intermediate Similarity NPD4661 Approved
0.7299 Intermediate Similarity NPD7228 Approved
0.7294 Intermediate Similarity NPD6234 Discontinued
0.729 Intermediate Similarity NPD6233 Phase 2
0.7287 Intermediate Similarity NPD7870 Phase 2
0.7287 Intermediate Similarity NPD7871 Phase 2
0.7278 Intermediate Similarity NPD4967 Phase 2
0.7278 Intermediate Similarity NPD4965 Approved
0.7278 Intermediate Similarity NPD4308 Phase 3
0.7278 Intermediate Similarity NPD4966 Approved
0.7273 Intermediate Similarity NPD4625 Phase 3
0.7273 Intermediate Similarity NPD6823 Phase 2
0.7268 Intermediate Similarity NPD6535 Approved
0.7268 Intermediate Similarity NPD6534 Approved
0.7267 Intermediate Similarity NPD9717 Approved
0.7263 Intermediate Similarity NPD8055 Clinical (unspecified phase)
0.7263 Intermediate Similarity NPD7701 Phase 2
0.7255 Intermediate Similarity NPD2861 Phase 2
0.7246 Intermediate Similarity NPD5890 Approved
0.7246 Intermediate Similarity NPD5889 Approved
0.7232 Intermediate Similarity NPD7685 Pre-registration
0.7225 Intermediate Similarity NPD7184 Clinical (unspecified phase)
0.7216 Intermediate Similarity NPD1729 Discontinued
0.7215 Intermediate Similarity NPD4538 Approved
0.7215 Intermediate Similarity NPD4537 Clinical (unspecified phase)
0.7215 Intermediate Similarity NPD4536 Approved
0.7205 Intermediate Similarity NPD5698 Clinical (unspecified phase)
0.7205 Intermediate Similarity NPD2654 Approved
0.72 Intermediate Similarity NPD1091 Approved
0.7197 Intermediate Similarity NPD447 Suspended
0.7197 Intermediate Similarity NPD1899 Clinical (unspecified phase)
0.7188 Intermediate Similarity NPD7875 Clinical (unspecified phase)
0.7188 Intermediate Similarity NPD7874 Approved
0.717 Intermediate Similarity NPD651 Clinical (unspecified phase)
0.717 Intermediate Similarity NPD5588 Approved
0.717 Intermediate Similarity NPD5960 Phase 3
0.7168 Intermediate Similarity NPD7229 Phase 3

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data